Utilisation of antibiotic therapy in community practice

Irish Medical Journal

Volumn 101, Issue 9, 2008, Pages

  McGowan, B ^a   Bergin, C ^a   Bennett, K ^a   Barry, M ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL INFECTION; CLINICAL PRACTICE; COMMUNITY CARE; DATA BASE; HUMAN; MULTIDRUG RESISTANCE; OUTPATIENT; RISK FACTOR; STATISTICS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMMUNITY HEALTH SERVICES; DATABASES AS TOPIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS;

EID: 58149401749     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bronzwaer SL. Cars O. Buchholz. et al., A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases. 2002; 8: 278-282.
2. Health Protection Surveillance Centre, A strategy for the control of Antimicrobial resistance in Ireland. 2001.
3. Department of Health, Standing Medical Advisory Committee Subgroup on Antimicrobial Resistance. The path of least resistance. 1998.
4. Goossens H. Ferech M. Vander Stichele R. et al., Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: 579-587.
5. Goossens H. Guillemot D. Ferech M. et al., National campaigns to improve antibiotic use. Eur J Clin Pharmacology. 2006; 62: 373-379.
6. http://mrw.interscience.wiley.com/cochrane/cochrane_clsysrev_articles_fs.html.
7. European Surveillance of Antimicrobial Resistance, EARSS Manual 2005.
8. World Health Organisation., Antimicrobial resistance Monitoring Programme. WHO Drug Information. 1997; 11: 248-249.
9. General Medical Services (Payments) Board, Report for the year ended 31st December 2004.-17.
10. Ferech L. Coenen S. Malhotra-Kumar S. et al., European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. Journal of Antimicrobial Chemotherapy. 2006.
11. Bauraind I. Lopez-Lozano JM. Beyaert A. et al., Association between antibiotic sales and public campaigns for the appropriate use. JAMA 2004; 292: 2468-2470.
12. Ferech M. Coenen S. Dvorakova K. et al., European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. Journal of Antimicrobial Chemotherapy, 2006.
13. Cohen ML., Antibiotic use. In Antimicrobial Resistance:Issues and Options. Workshop Report. National Academy Press. Washington D.C., 1998.
14. Macfarlane J. Holmes W. Macfarlane R. Britten N, Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice:questionnaire study. British Medical Journal. 1997; 315: 1211-1214.
15. Seppala H. Klaukka T. Vuopio-Varkila J et al., The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New England Journal Medicine. 1997; 337: 441-446.
16. Tenover FC. Hughes JM., WHO Scientific Working Group on monitoring and management of bacterial resistance to antimicrobial agents. Emerging Infectious Diseases. 1995; 1:37.
17. Anita G. Carrie and George G Zhanel., Antibacterial Use in Community Practice. Drugs. 1999; 57: 871-881.
18. Couper MR, Strategies for the rational use of antimicrobials. Clinical Infectious Diseases. 1997; 24: S154-S156.
19. Scheckler WE. Brimhall D. Buck AS et al., Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Infection Control and Hospital Epidemiology. 1998; 19: 114-124.
20. Haley RW. Culver DH. White JW et al., The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. American Journal of Epidemiology. 1985; 121:182-205.
21. Goldmann DA. Weinstein RA. Wenzel RP et al., Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. Journal of the American Medical Association. 1996; 275: 234-240.
22. Macfarlane JT. Holmes WF. Macfarlane RM., Reducing reconsultations for acute lower respiratory tract illness with an information leaflet: a randomised controlled study of patients in primary care. British Journal of General Practice. 1997; 47: 719-722.
23. Bradley CP, Factors which influence the decision wheither or not to prescribe: the dilemma facing general practioners. British Journal of General Practice. 1992; 42: 454-458.
24. Holmes WF. Macfarlane JT. Macfarlane RM. Lewis S., The influence of antibiotics and other factors on reconsultation for acute lower respiratory tract illness in primary care. British Journal of General Practice, 1997; 47: 815-818.
25. Bergman M, Huikko S, Pihlajamäki M, Laippala P, Palva E, Huovinen P, Seppälä H; Finnish Study Group for Antimicrobial Resistance (FiRe Network). Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis. 2004 May 1;38:1251-6. Epub 2004 Apr 14.
26. British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Adults 2004 Update, http://www.britthoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidel ines/MACAPrevisedApr04.pdf.
27. European Study on Community-acquired Pneumonia (ESOCAP) Committee. European Respiratory Society (ERS) Task Force Report; Guidelines for the Management of adult community-acquired lower respiratory tract infections. http://www.ers-education.org/pages/default.aspx?id=725.
28. The National Institute for Health and Clinical Excellence. CG69 Respiratory tract infections: full guideline http://www.nice.org.uk/Guidance/CG69/Guidance/pdf/English.
29. LeBlanc L, Pépin J, Toulouse K, Ouellette MF, Coulombe MA, Corriveau MP, Alary ME. Fluoroquinolones and risk for methicillinresistant Staphylococcus aureus, Canada. Emerg Infect Dis. 2006 Sep;12:1398-405.
30. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008 Jan;61:26-38. Epub 2007 Nov 6.
31. Schneider-Lindner V, Delaney JA, Dial S, Dascal A, Suissa S. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis. 2007 Jul;13:994-1000.